Organon Pharma Indonesia PT (ISX:SCPI) Probability of Financial Distress (%)

View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Probability of Financial Distress (%)?

Organon Pharma Indonesia PT does not have enough data to calculate Probability of Financial Distress (%).

Organon Pharma Indonesia PT Probability of Financial Distress (%) Historical Data

The historical data trend for Organon Pharma Indonesia PT's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Probability of Financial Distress (%) Chart

Organon Pharma Indonesia PT Annual Data

Trend

Probability of Financial Distress (%)

Organon Pharma Indonesia PT Quarterly Data

Probability of Financial Distress (%)

Competitive Comparison of Organon Pharma Indonesia PT's Probability of Financial Distress (%)

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon Pharma Indonesia PT's Probability of Financial Distress (%) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Probability of Financial Distress (%) falls into.

Organon Pharma Indonesia PT (ISX:SCPI) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

Organon Pharma Indonesia PT Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Probability of Financial Distress (%)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920

Website

https://www.organon.com/indonesia

Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines